Medial Research Network

Case History 3 - Retention

Indication: Oncology

Country: United Kingdom 
Sites: 3 sites in total
Number of Patients: 57
Total Number of Visits Conducted: Over 2,200 across 3 years


MRN’s Home Trial Support service was used in a long term complex study, which also required compounding within 24 hours of drug administration for 57 patients in 3 sites across the UK. Infusions were administered every two weeks for an average of 3 years in follow up treatment phase, alternating between home and inpatient administration. MRN trained 40 nurses to ensure continuity of care.


• The study achieved a patient retention rate of 98%; only 1 patient was lost from this study.
• A post trial patient assessment was also carried out yielding the following positive outcomes:


 How do you rate your homecare experience?



For more case histories, click here.


Sign up for our Newsletter